Annual report pursuant to Section 13 and 15(d)

Consolidated Statement of Equity Consolidated Statement of Equity

v3.8.0.1
Consolidated Statement of Equity Consolidated Statement of Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings (Deficit) [Member]
Noncontrolling Interest [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Directors
Common Stock [Member]
Employees
Common Stock [Member]
Executive Officers
Common Stock [Member]
Balance, beginning of period, shares at Mar. 31, 2015   32,082,393              
Balance, beginning of period at Mar. 31, 2015 $ 271,766 $ 32 $ 213,885 $ 99,249 $ 0 $ (41,400)      
Issuance of common stock in exercise of stock options, shares 69,704 29,056              
Issuance of common stock in exercise of stock options $ 240   240            
Issuance of restricted stock as deferred compensation to employees and directors, shares             18,578    
Issuance of common stock in lieu of compensation, shares               69,704 22,989
Stock compensation expense 3,749   3,749            
Excess tax deduction from stock options 92   92            
Repurchase of employee stock units on vesting (1,265)   (1,265)            
Net income (loss) 23,009     23,009          
Foreign curency translation adjustment (3,242)         (3,242)      
Interest rate swap (340)         (340)      
Other 413         413      
Non-controlling interest in acquisition 3,638       3,638        
Income attributable to non-controlling interests 641       641        
Balance, end of period, shares at Mar. 31, 2016   32,222,720.00              
Balance, end of period at Mar. 31, 2016 298,701 $ 32 216,701 122,258 4,279 (44,569)      
Issuance of common stock in exercise of stock options, shares   43,121              
Issuance of common stock in exercise of stock options $ 250   250            
Issuance of restricted stock as deferred compensation to employees and directors, shares 19,824           19,824    
Issuance of common stock in lieu of compensation, shares               47,179 32,709
Stock compensation expense $ 3,402   3,402            
Excess tax deduction from stock options (1,069)   (1,069)            
Net income (loss) 14,641     14,641          
Foreign curency translation adjustment (4,536)         (4,536)      
Interest rate swap 791         791      
Other (21)         (21)      
Income attributable to non-controlling interests $ 343       343        
Balance, end of period, shares at Mar. 31, 2017 32,365,553 32,365,553.000              
Balance, end of period at Mar. 31, 2017 $ 312,502 $ 32 219,284 136,899 4,622 (48,335)      
Issuance of common stock in exercise of stock options, shares   42,636              
Issuance of common stock in exercise of stock options 300   300            
Issuance of restricted stock as deferred compensation to employees and directors, shares   20,216         20,216    
Issuance of common stock in lieu of compensation, shares               43,445 20,489
Stock compensation expense 3,519   3,519            
Excess tax deduction from stock options (481)   (481)            
Net income (loss) 11,913     11,913          
Foreign curency translation adjustment 12,030         12,030      
Interest rate swap 34         34      
Other (270)         (270)      
Income attributable to non-controlling interests $ 1,306       1,306        
Balance, end of period, shares at Mar. 31, 2018 32,492,339 32,492,339.000              
Balance, end of period at Mar. 31, 2018 $ 340,853 $ 32 $ 222,622 $ 148,812 $ 5,928 $ (36,541)